These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8958597)

  • 41. Smoking cessation and schizophrenia.
    Leonard S; Adams CE
    Am J Psychiatry; 2006 Nov; 163(11):1877. PubMed ID: 17074936
    [No Abstract]   [Full Text] [Related]  

  • 42. Negative effects of a smoking ban on an inpatient psychiatry service.
    Greeman M; McClellan TA
    Hosp Community Psychiatry; 1991 Apr; 42(4):408-12. PubMed ID: 2050355
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Psychological and physiological dependence in smokers and there effect on motivation for smoking cessation].
    Schoberberger R; Fagerström KO; Kunze M
    Wien Med Wochenschr; 1995; 145(4):70-3. PubMed ID: 7778321
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of cigarette smoking status with respect to symptomatic manifestation in first-episode schizophrenia patients.
    Misiak B; Kiejna A; Frydecka D
    Compr Psychiatry; 2015 Apr; 58():146-51. PubMed ID: 25595518
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Group treatment for smoking cessation among persons with schizophrenia.
    Addington J
    Psychiatr Serv; 1998 Jul; 49(7):925-8. PubMed ID: 9661227
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Smoking cessation in schizophrenia. General practice guidelines.
    Strasser K; Moeller-Saxone K; Meadows G; Hocking B; Stanton J; Kee P
    Aust Fam Physician; 2002 Jan; 31(1):21-4. PubMed ID: 11840883
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reactivity to smoking cues: mediating roles of nicotine dependence and duration of deprivation.
    Payne TJ; Smith PO; Sturges LV; Holleran SA
    Addict Behav; 1996; 21(2):139-54. PubMed ID: 8730517
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nicotine uses and abuses: from brain probe to public health menace.
    Pomerleau OF; Pomerleau CS
    J Subst Abuse; 1989; 1(3):253-7. PubMed ID: 7580217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of emergent psychiatric symptoms during smoking cessation.
    Aubin HJ
    Curr Med Res Opin; 2009 Feb; 25(2):519-25. PubMed ID: 19193000
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of varying cigarette deprivation duration on cognitive and performance tasks.
    Hatsukami D; Fletcher L; Morgan S; Keenan R; Amble P
    J Subst Abuse; 1989; 1(4):407-16. PubMed ID: 2485288
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia.
    Chou KR; Chen R; Lee JF; Ku CH; Lu RB
    Int J Nurs Stud; 2004 Mar; 41(3):321-30. PubMed ID: 14967189
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Why do schizophrenic patients smoke?].
    Cattapan-Ludewig K; Ludewig S; Jaquenoud Sirot E; Etzensberger M; Hasler F
    Nervenarzt; 2005 Mar; 76(3):287-94. PubMed ID: 15448920
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Smoking, nicotine and psychiatric disorders: evidence for therapeutic role, controversies and implications for future research.
    Dursun SM; Kutcher S
    Med Hypotheses; 1999 Feb; 52(2):101-9. PubMed ID: 10340289
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessing nicotine dependence: a comparison of the Fagerström Tolerance Questionnaire (FTQ) with the Fagerström Test for Nicotine Dependence (FTND) in a clinical sample.
    Payne TJ; Smith PO; McCracken LM; McSherry WC; Antony MM
    Addict Behav; 1994; 19(3):307-17. PubMed ID: 7942248
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sleep changes in smokers before, during and 3 months after nicotine withdrawal.
    Jaehne A; Unbehaun T; Feige B; Cohrs S; Rodenbeck A; Schütz AL; Uhl V; Zober A; Riemann D
    Addict Biol; 2015 Jul; 20(4):747-55. PubMed ID: 24797355
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acoustic startle and prepulse inhibition predict smoking lapse in posttraumatic stress disorder.
    Vrana SR; Calhoun PS; Dennis MF; Kirby AC; Beckham JC
    J Psychopharmacol; 2015 Oct; 29(10):1070-6. PubMed ID: 26253620
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors affecting smoking in schizophrenia.
    Beratis S; Katrivanou A; Gourzis P
    Compr Psychiatry; 2001; 42(5):393-402. PubMed ID: 11559866
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination Extended Smoking Cessation Treatment Plus Home Visits for Smokers With Schizophrenia: A Randomized Controlled Trial.
    Brody AL; Zorick T; Hubert R; Hellemann GS; Balali S; Kawasaki SS; Garcia LY; Enoki R; Abraham P; Young P; McCreary C
    Nicotine Tob Res; 2017 Jan; 19(1):68-76. PubMed ID: 27613888
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biobehavioral research on nicotine use in women.
    Pomerleau CS; Pomerleau OF; Garcia AW
    Br J Addict; 1991 May; 86(5):527-31. PubMed ID: 1859915
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nerve growth factor and smoking cessation.
    Lang UE; Gallinat J; Kuhn S; Jockers-Scherübl mC; Hellweg R
    Am J Psychiatry; 2002 Apr; 159(4):674-5. PubMed ID: 11925315
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.